Skip to main content
. 2022 May 13;25(3):207–217. doi: 10.4048/jbc.2022.25.e21

Figure 2. Access to other early BC systemic treatments not listed in the WHO-EML or not provided an ESMO-MCBS score of A or B.

Figure 2

BC = breast cancer; WHO-EML = World Health Organization Model List of Essential Medicines; ESMO-MCBS = European Society for Medical Oncology-Magnitude of Clinical Benefit Scale; CSMBS = Civil Servant Medical Benefit Scheme; SSS = Social Security Scheme; UCS = Universal Coverage Scheme; ML = MediShield Life; SAR = special administrative region; NA = not available; FR = fully reimbursed; NR = non-reimbursed; PR = partially reimbursed.

*With specific conditions; Only for node-positive BC.